Dartford and Gravesham NHS Trust

The Dartford and Gravesham NHS Trust incorporates Darent Valley Hospital in Dartford http://www.dvh.nhs.uk/
Data completeness for risk adjustment for 2019-2020 poor at time of analysis. It had improved markedly by time of publication

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • 7-day access to face-to-face palliative care services

Data Quality
All Patients: Trust Network National
Number of patients in Audit 187 1240 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 70 77 86
– Performance status (%) 44 70 89
Patients having major resection: Trust Network National
Number of patients in Audit N/A 500 19631
ASA grade 1 (%) N/A 4 9
ASA grade 2 (%) N/A 61 53
ASA grade 3 (%) N/A 32 31
ASA grade 4+ (%) N/A 2 2
ASA grade not recorded (%) N/A N/A 4
Data completeness of:
7 Audit items for risk-adjustment (%) N/A 49 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 187 1240 35779
Seen by Clinical Nurse Specialist (%) 88 85 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit N/A 500 19614
Distant metastases (%) N/A 5 5
Urgent or emergency surgery (%) N/A 12 15
At least 12 lymph nodes excised (%) N/A 44 84
Laparoscopic surgery attempted (%) N/A 71 72
Risk-adjusted length of stay > 5 days (%) N/A 45 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 44 N/A 10747
Adjuvant chemotherapy (%) 68 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 10 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) N/A N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit N/A N/A 4251
Neoadjuvant therapy (%) N/A N/A 33
Circumferential resection margin: Recorded (%) N/A 61 89
Circumferential resection margin: Negative (%) N/A 60 83
Rectal volume N/A N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 103 517 19644
APER/Hartmanns (%) 33 43 37

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd